SEC 13F Intelligence

Boxer Capital, LLC / AM6

Boxer Capital, LLC’s Amicus Therapeutic Position

Does Boxer Capital, LLC own Amicus Therapeutic (AM6)? Not currently — the last reported position was 2.33M shares worth $28M in Q3 2023; the fund’s latest 13F (Q4 2024) no longer reports it.

Position Value
$28M
Q3 2023
Shares
2.33M
% of Portfolio
+1.51%
Quarters Held
18
position exited

Position History AM6

Reported value by quarter
Q2 ’19: $29MQ2 ’19Q3 ’19: $19MQ4 ’19: $23MQ1 ’20: $21MQ1 ’20Q2 ’20: $35MQ3 ’20: $33MQ4 ’20: $54MQ4 ’20Q1 ’21: $23MQ2 ’21: $22MQ3 ’21: $22MQ3 ’21Q4 ’21: $27MQ1 ’22: $22MQ2 ’22: $25MQ2 ’22Q3 ’22: $24MQ4 ’22: $28MQ1 ’23: $25,784Q1 ’23Q2 ’23: $29,202Q3 ’23: $28Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 20232.33M$28M+1.51%
Q2 20232.33M$29,202+1.35%
Q1 20232.33M$25,784+1.27%
Q4 20222.33M$28M+1.50%
Q3 20222.33M$24M+1.37%
Q2 20222.33M$25M+1.58%
Q1 20222.33M$22M+1.13%
Q4 20212.33M$27M+1.04%
Q3 20212.33M$22M+0.78%
Q2 20212.33M$22M+0.79%
Q1 20212.33M$23M+0.78%
Q4 20202.33M$54M+1.73%
Q3 20202.33M$33M+1.13%
Q2 20202.33M$35M+1.54%
Q1 20202.33M$21M+1.46%
Q4 20192.33M$23M+1.28%
Q3 20192.33M$19M+1.35%
Q2 20192.33M$29M+2.49%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital, LLC’s full portfolio or all institutional holders of AM6.